Blog

Asian Pacific Health Care Venture, Inc. (APHCV) would like to provide information about issues that may affect our patients, staff and the communities we serve.

Measure ER is a Los Angeles County ballot initiative that will appear on the June 2, 2026 election ballot. This information provides an overview of the measure and what it could mean for healthcare access for our patients and our communities.

What is Measure ER?

Measure ER is a proposed temporary ½-cent (0.5%) increase in the Los Angeles County sales tax for five years.

If approved by voters, the measure is estimated to generate approximately $1 billion per year to support healthcare and other essential services across the county.

Key details:

• Tax: About 5 cents per $10 spent
• Duration: 5 years only (automatically expires in October 2031)
• Exemptions:
  • Groceries
  • Prescription medications
  • Medical equipment

The measure also includes independent oversight and public reporting on how funds are used.

Why is Measure ER being proposed?

Recent federal policy changes will reduce federal funding for Medi-Cal and other health programs.

As a result:

• An estimated 700,000 L.A. County residents are projected to lose health insurance
• When disaster strikes—fires, earthquakes, public health crises—we rely on our County hospitals. Measure ER keeps our public health infrastructure and other essential services strong and ready—for all of us.
• Seven of LA County’s Public Health clinics have closed as a result of cuts to grants from the federal goverment, which means these clinics are not expected to reopen.
• These cuts currently threaten disease surveillance, water safety, and other essential services that protect public health.
• When emergency rooms and community clinics close, patients do not simply disappear; they crowd into the nearest hospital or primary care facility, which increases wait times, costs, and worsens care for everyone. Measure ER is a temporary-emergency measure to help stabilize our healthcare system in the wake of urgent funding shortfalls from the federal government.
• Hospitals, clinics and public health programs face $2.4 billion in lost revenue over 3 years.

What will the passage of Measure ER mean for healthcare in Los Angeles County?

If passed, Measure ER funding will support:

• Safety-net hospitals and emergency care
• Community clinics like APHCV.
• Public health programs
• School-based health services
• In-home support services for seniors and individuals with disabilities
• Other essential health and human services

The goal is to help sustain healthcare services and access across Los Angeles County in the face of reduced federal funding.

What could the passage of Measure ER mean for APHCV?

Nearly about 90% of our patients at APHCV rely on Medicaid.

If Measure ER passes:

• The patients who lose Medi-Cal will be able to continue to get care as Measure ER will be able to pay for their care. APHCV can continue to keep our doors open for those who lose Medi-Cal.
• These funds will help to sustain the continued operation of the local hospitals, emergency care, and intervening the spread of communicable diseases such as TB, Hepatitis, etc.). This helps APHCV and our patients and communities stay safer.

How can I learn more or participate?

We encourage everyone to review information from official sources and participate in the voting process.

Key dates:

• Ballots mailed: May 4, 2026
• Early in-person voting begins: May 23, 2026
• Election Day: June 2, 2026

Official resources:

Measure ER Fact Sheet: Learn more
Los Angeles County Registrar: www.lavote.gov
California Secretary of State: www.sos.ca.gov/elections

The American Heart Association presents outpatient program achievement awards for proven dedication to ensuring patients have access to best practices that reduce risk of heart disease and stroke

LOS ANGELES, CA, Oct. 8, 2025 — Asian Pacific Health Care Venture, Inc. has received three American Heart Association outpatient program achievement awards in recognition for its commitment to reducing the risk of heart disease and stroke by improving high cholesterol, Type 2 diabetes and blood pressure management. The awards recognize a commitment to following the latest evidence- and science-based care guidelines.

Nearly half of all adults in the U.S. have some form of cardiovascular disease, including heart attack, stroke or heart failure.[1] High cholesterol, Type 2 diabetes and uncontrolled high blood pressure are leading risk factors for cardiovascular disease, but with timely diagnosis, research-based treatment and education, these conditions can be managed.

The outpatient achievement award programs put the unparalleled expertise of the American Heart Association to work for health care organizations nationwide, helping ensure the care provided to patients is aligned with the latest evidence- and research-based guidelines. As a participant in the Target: BP, Check. Change. Control. Cholesterol., Target: Type 2 Diabetes programs, Asian Pacific Health Care Venture, Inc. was recognized after demonstrating how their organization has committed to improving risk factor management for patients.

This year, Asian Pacific Health Care Venture, Inc. received these achievement awards:

• The American Heart Association’s Change. Control. Cholesterol™ Gold
• The American Heart Association’s Target: Type 2 Diabetes℠ Gold
• Target: BP™ Gold+ recognition jointly presented by the American Heart Association and the American Medical Association.

“Heart disease and stroke remain the leading causes of death for Americans, and addressing Type 2 diabetes, cholesterol, blood pressure management is key for better cardiovascular health,” said Howard Haft, M.D., MMM, CPE, FACPE, member of the American Heart Association’s National Quality Oversight Committee. “The American Heart Association is pleased to recognize Asian Pacific Health Care Venture, Inc. for its commitment to managing patient risk factors related to high blood pressure, high cholesterol and Type 2 diabetes.”

[1] Martin S, et al. 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association. Circulation. 2024:149(8). https://doi.org/10.1161/CIR.0000000000001209.